122 related articles for article (PubMed ID: 38450196)
1. Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer.
Frontiers Editorial Office
Front Oncol; 2024; 14():1383394. PubMed ID: 38450196
[TBL] [Abstract][Full Text] [Related]
2. A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer.
Zhan Z; Mei J; Zhou X; Jiang S; Li D; Wang X
Front Oncol; 2022; 12():1085305. PubMed ID: 36561518
[TBL] [Abstract][Full Text] [Related]
3. Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():721663. PubMed ID: 34249769
[TBL] [Abstract][Full Text] [Related]
4. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.
Frontiers Editorial Office
Front Oncol; 2021; 11():721658. PubMed ID: 34277459
[TBL] [Abstract][Full Text] [Related]
5. Retraction.
Open Biomed Eng J; 2018; 12():91. PubMed ID: 37915339
[TBL] [Abstract][Full Text] [Related]
6. Retraction: The oncolytic virus in cancer diagnosis and treatment.
Frontiers Editorial Office
Front Oncol; 2023; 13():1320477. PubMed ID: 38023159
[TBL] [Abstract][Full Text] [Related]
7. Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway.
Frontiers Editorial Office
Front Oncol; 2021; 11():707608. PubMed ID: 34136414
[TBL] [Abstract][Full Text] [Related]
8. Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
Frontiers Editorial Office
Front Oncol; 2021; 11():738970. PubMed ID: 34532292
[TBL] [Abstract][Full Text] [Related]
9. Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1294881. PubMed ID: 37841426
[TBL] [Abstract][Full Text] [Related]
10. Retraction: Ppm1b Negatively Regulates 3-Bromopyruvic Acid Induced Necroptosis in Breast Cancer Cells.
Frontiers Editorial Office
Front Oncol; 2021; 11():757083. PubMed ID: 34513719
[TBL] [Abstract][Full Text] [Related]
11. Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():734761. PubMed ID: 34350126
[TBL] [Abstract][Full Text] [Related]
12. Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics.
Frontiers Editorial Office
Front Oncol; 2023; 13():1343833. PubMed ID: 38130994
[TBL] [Abstract][Full Text] [Related]
13. Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298871. PubMed ID: 37881488
[TBL] [Abstract][Full Text] [Related]
14. Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer.
Office FE
Front Oncol; 2023; 13():1228367. PubMed ID: 37377910
[TBL] [Abstract][Full Text] [Related]
15. Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
Frontiers Editorial Office
Front Oncol; 2021; 11():839904. PubMed ID: 35036357
[TBL] [Abstract][Full Text] [Related]
16. Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():694036. PubMed ID: 34041039
[TBL] [Abstract][Full Text] [Related]
17. Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis.
Frontiers Editorial Office
Front Oncol; 2024; 14():1383410. PubMed ID: 38444679
[TBL] [Abstract][Full Text] [Related]
18. Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin.
Frontiers Editorial Office
Front Oncol; 2023; 13():1337635. PubMed ID: 38130993
[TBL] [Abstract][Full Text] [Related]
19. Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8.
Frontiers Editorial Office
Front Oncol; 2023; 13():1307324. PubMed ID: 37927471
[TBL] [Abstract][Full Text] [Related]
20. Retraction: OTUB2 facilitates tumorigenesis of gastric cancer through promoting KDM1A-mediated stem cell-like properties.
Frontiers Editorial Office
Front Oncol; 2023; 13():1209867. PubMed ID: 37287909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
